Lucentis Vs. Avastin: The Competition For Treatment Of Macular Degeneration
Treatment Of Macular Degeneration
When Lucentis was presented to the Food and Drug Administration(FDA), they approved it after a lengthy testing period. There were celebrations going on all over the eye care world. Not only had they found an effective treatment for AMD, but it would be hefty in the pocket book department. The day they received the good news was in 2006. Lucentis was a step into the technology age.
Another drug we will discuss is Avastin. If you have received a diagnosis of macular degeneration (AMD), you are well aware of these two drugs. The debate between doctors is which drug is more effective and which is proper to use. If you are using one of these two treatments, then we recommend you read this article to become more aware. Not only will you be aware, you will also be able to inform your friends and loved ones as well.
Does Avastin work as well as Lucentis in treating Macular Degeneration?
The cost of both drugs is very different. Lucentis is way more expensive than Avastin because it is FDA approved for the treatment of macular degeneration. Your cost is high for treatment with Lucentis versus a much lower cost per treatment for Avastin. Doctors argue that Avastin is just as effective as Lucentis but at a more affordable price. Besides the cost difference in the two drugs, there is another concern that arises. Avastin came into being for treatment of colon cancer and other cancers. It has not been FDA approved for the treatment of AMD and is considered “off-label” for this purpose.
Knowing this, there is not enough evidence either way to answer the question of which drug works best. Back in October of 2007, Genentech, the company which markets both drugs, had a plan. They were going to limit availability of Avastin for ocular uses. Some doctors say that the drug is as effective as, if not more so than, Lucentis, but others claim that it is not as effective.
Where the Lucentis and Avastin debate stands today
Some doctors expressed safety concerns when asked about Avastin as a macular degeneration treatment. As a matter-of-fact, they refused to prescribe it. Still, others will not prescribe anything else. The debate continues to this day about which drug works best, and it’s been found that either drug can work well. Most of the time, a patient will respond better to one drug or the other, but both Lucentis and Avastin have shown efficacy.
If you are having either one injected, you are in good shape according to most in the medical field. One is more expensive than the other, but the effects are the same. No matter which one your doctor prescribes, that treatment is right for you, but if you are having complications, let your doctor know, because there may be other issues. Have you gotten injections for macular degeneration? We’d love to hear about your experience!
Dr. Jenna Zigler
- Dr. Jenna Zigler